Home › Essential Thrombocythemia › Tennessee › Nashville
Essential Thrombocythemia clinical trials in Nashville, TN
4 studies for Essential Thrombocythemia are looking for participants at sites in and around Nashville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
RecruitingPhase 2
- Vanderbilt University/Ingram Cancer Center, Nashville
A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia
RecruitingPhase 3
- Vanderbilt University Medical Center, Nashville
- Vanderbilt University Medical Center, Nashville
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
RecruitingPhase 1
- Tristar Bmt/Tcto, Nashville
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
RecruitingPhase 1
- Vanderbilt University Medical Center, Nashville
Essential Thrombocythemia trials in other cities
- New York City, NY7 studies
- Durham, NC6 studies
- Chicago, IL4 studies
- Boston, MA4 studies
- Baltimore, MD4 studies
- Miami, FL4 studies
- Salt Lake City, UT4 studies
- Mountain View, CA4 studies
- Irvine, CA3 studies
- Los Angeles, CA3 studies
- Columbus, OH3 studies
- St. Louis, MO3 studies
Other studies in Nashville
- Non-Small Cell Lung Cancer97 studies
- Breast Cancer80 studies
- Metastatic Cancer70 studies
- Colorectal Cancer69 studies
- Cancer (all types)65 studies
- Ovarian Cancer49 studies
- Prostate Cancer42 studies
- Lung Cancer40 studies
- Head and Neck Squamous Cell Carcinoma39 studies
- Pancreatic Cancer39 studies
- Endometrial Cancer38 studies
- Melanoma33 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.